CEO, Ben Thomas, and CCO, Dermot Tierney, joined Moira Gunn from BioTech Nation to discuss exactly why the company was formed and how, with the assistance of AI and machine learning, it’s technology can identify novel biological drug and nutraceutical candidates
Click here to listen.
Podcast taken from: https://www.biotechnation.com/episodes/why-do-ai-one-way-when-you-can-do-it-25-dr-ben-thomas-and-dermot-tierny-ceo-cco-amply-discovery
The below article is taken from the Derry Journal. In October this year, Caldwell & Robinson Solicitors, in association with
Investment Fund for Northern Ireland and 57 Stars support Lisburn company’s commitment to addressing global healthcare challenges
Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.
5th Floor
Craig Plaza
51 Fountain Street
Belfast, BT1 5EA
Co. Antrim
T: +44 (0)28 9032 6465
F: +44 (0)28 9032 6473
E: info@clarendon-fm.co.uk
Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.
© 2025 Clarendon Fund Managers. All rights reserved.